MedTrace Logo

Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers

NCT03163680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 295

Last updated 2018-07-10

No results posted yet for this study

Summary

Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding

Conditions

  • Gastroduodenal Ulcer
  • Marginal Ulcer
  • Peptic Ulcer Hemorrhage

Interventions

DRUG

Omeprazole 40 MG

Omperazole 40 mg twice daily

Sponsors & Collaborators

  • Damascus Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2018-05-01
Completion
2018-06-04

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163680 on ClinicalTrials.gov